SCHEMBL8930654

SCHEMBL8930654

CC1(C)Oc2c(S)c3c(c(C(O)(c4c5c(c(S)c6c4OC(C)(C)O6)OC(C)(C)O5)c4c5c(c(S)c6c4OC(C)(C)O6)OC(C)(C)O5)c2O1)OC(C)(C)O3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930675 0.66
SCHEMBL12741037 0.48 TSHR (0.38)
SCHEMBL9998917 0.42
Tert-Butanol SCHEMBL27517178 0.39
SCHEMBL23149820 0.37
SCHEMBL19921920 0.37
SCHEMBL652559 0.37
SCHEMBL911361 0.37
SCHEMBL7948270 0.37
Tert-Butanol SCHEMBL10588934 0.37

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0418863-B1 NMDA antagonists MERRELL DOW PHARMA (US) 1995-01-04 EP claimed
US-5599522-A CONTRAST ENHANCING AGENTS NYCOMED IMAGING AS (NO) 1997-02-04 US disclosed
EP-0515458-B1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI NYCOMED INNOVATION AB (SE) 1995-08-23 EP disclosed
EP-0515458-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI. HAFSLUND NYCOMED INNOVATION (SE) 1992-12-02 EP disclosed
WO-1991012024-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI HAFSLUND NYCOMED INNOVATION AB (SE) 1991-08-22 WO disclosed